Why Wounds Heal Slower After Menopause: What the Shilajit Research Shows

• Why does a cut take longer to heal after menopause?
• What does the actual estrogen and wound healing research show?
• What changed in the tissue itself?
• What does shilajit's own research show about the same repair signals?
• Is there any research on fulvic acid and wounds directly?
• How does this compare with what most people reach for first?
• Common questions about wound healing and shilajit

Why does a cut take longer to heal after menopause?

Ask most women over 50 and they will tell you the same thing without being prompted. A scrape that would have closed in five or six days now takes ten. A surgical incision leaves a mark that stays pink for months. It is not imagination, and it is not just a matter of counting more birthdays.

Shilajit and its active compound, fulvic acid, connect to this in a specific way. Human research has measured shilajit's effect on the same collagen genes and tissue-repair signals that a wound depends on to close. That research was not built around cuts and stitches. It was built around skin and muscle tissue generally, and it lands on the exact biology a slow-healing wound runs on.

The estrogen link nobody explains at the doctor's office

Estrogen receptors live inside fibroblasts, the cells that manufacture new collagen at a wound site, and inside the immune cells that control how much inflammation shows up and how long it lingers. When estrogen falls, both of those jobs get done less efficiently. That is not a theory. It has been measured directly, in a human trial, described next.

What does the actual estrogen and wound healing research show?

Ashcroft and colleagues (1999) ran a randomized, double-blind trial in 36 healthy elderly adults, 18 women averaging 74 years old and 18 men averaging 71. Each person had a topical estrogen patch, or an identical placebo patch, attached to the upper inner arm for 24 hours. Two small 4-millimeter punch-biopsy wounds were then made through the treated skin, and the wounds were surgically excised and examined at either day 7 or day 80.

Compared to placebo, the estrogen-treated wounds showed a smaller wound size at day 7, higher collagen levels at both day 7 and day 80, higher fibronectin (a protein that helps new tissue scaffold together) at day 7, and greater wound strength by day 80.

What actually changed in the tissue

The researchers did not stop at measuring the wound from the outside. They looked at what was happening at the cellular level, and found a specific mechanical reason for the difference.

• Wound size was measurably smaller in the estrogen group by day 7
• Collagen levels were higher at both the day 7 and day 80 marks
• Fibronectin, the scaffolding protein new tissue is built on, was elevated at day 7
• Wound tensile strength, how well the healed tissue held together, was greater by day 80
• Estrogen reduced levels of elastase, an enzyme that breaks down tissue, by lowering the number of neutrophils (a type of inflammatory immune cell) at the wound site
• In lab testing of isolated human neutrophils, estrogen directly slowed their movement toward the wound and changed how they stuck to tissue

The mechanism is not mysterious once you see the data laid out. Less runaway inflammation, more collagen, more scaffolding, and a stronger result. Every one of those measurements moved the same direction in a trial that included both men and women, with the women averaging 74, well past the age most of them would have gone through menopause.

Is there any research on fulvic acid and wounds directly?

Yes, though it is honest to be precise about what kind of research it is. Zhao and colleagues (2015) tested a purified, carbohydrate-derived fulvic acid, related to but not identical to Optimum's Altai-sourced shilajit, against 500 clinical bacterial and fungal isolates in the lab, then applied it topically to infected wounds in a rat model.

The fulvic acid showed strong antimicrobial activity against drug-resistant pathogens including MRSA, and topically treated wounds in the rats healed faster than untreated infected wounds, measured by wound size, tissue examination, and the activity of wound-healing genes. The inflammatory marker interleukin 6 dropped faster in the treated wounds too.

The honest ceiling on this one

That is an animal study of an infected wound, using a topical, purified fulvic acid product, not Optimum's oral shilajit and not a human trial.

We are not claiming it as proof that shilajit heals human wounds. A few distinctions are worth stating plainly:

• It was a rat model, not a human trial
• The product was applied topically, not taken orally like Optimum's shilajit
• It targeted infected wounds specifically, not general healing speed
• It is a related, purified fulvic acid product, not Optimum's Altai-sourced shilajit itself
• What it adds is a second, independent line of evidence that fulvic acid itself has real measured activity in wound tissue, alongside the human collagen-gene research below

What does shilajit's own research show about the same repair signals?

Shilajit's own human trials were not designed around wounds. They were designed around the same collagen and tissue-repair machinery a wound depends on, tested directly in skin and muscle biopsies.

Das and colleagues (2016) gave adults 500 milligrams of oral shilajit daily for 8 weeks, then biopsied muscle tissue directly. A cluster of 17 collagen and extracellular-matrix genes turned on, with the strongest single gene, a type III collagen gene, rising more than fivefold above baseline. Type III collagen is specifically the collagen type a body lays down first when repairing new tissue, before it matures into the tougher type I collagen.

A separate 14-week trial by Das and colleagues (2019) gave healthy middle-aged women shilajit at 125 or 250 milligrams twice daily and took real skin biopsies with gene-expression sequencing plus dermascopic perfusion imaging. At the higher dose, shilajit improved measured skin blood flow compared to baseline and placebo, and it turned on genes tied to blood-vessel growth and extracellular matrix repair, the two systems a healing wound leans on most.

Neither trial cut anyone open and measured how fast the cut closed. Both trials measured the underlying machinery, in real human tissue, and that machinery is the same machinery Ashcroft's team found estrogen driving in an actual wound.

How does this compare with what most people reach for first?

Most standard wound-care advice focuses on the outside of the wound. Here is how the three approaches stack up.

None of that makes basic wound care wrong. Keeping a wound clean and covered is still the right first move for any cut or incision. The research in this article sits underneath that advice, at the level of the collagen and inflammation machinery itself, and the honest limit stays the same throughout, no trial has stitched a wound closed on shilajit and timed it against placebo.

Shilajit's fulvic acid content is the mechanism behind the collagen-gene and skin-perfusion research described above, sourced from the Altai mountains and third-party lab tested for purity on every batch of Optimum Shilajit. No trial has measured it against wound-closure speed directly, and we say that plainly rather than imply a result the research has not shown.